Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers

Cited by (273)

Items 101–200 of 273

1. The role of biomarkers in the early detection of pancreatic cancer
   Michael Goggins · 2024 · Familial Cancer
2. Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study
   Ujjwal Mukund Mahajan, Bettina Oehrle, Elisabetta Goni, Oliver Strobel, Jörg Kaiser, Robert Grützmann, Jens Werner, Helmut Friess, Thomas Mathias Gress, T Seufferlein et al. · 2025 · The Lancet. Gastroenterology & hepatology
3. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications
   Aleksei A. Tikhonov, Olga Smoldovskaya, Guzel Feyzkhanova, Н. Е. Кушлинский, Alla Yu. Rubina · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
4. Syndecans and Pancreatic Ductal Adenocarcinoma
   Nausika Betriu, Juan Bertran-Mas, Anna Y. Andreeva, Carlos E. Semino · 2021 · Biomolecules
5. Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer
   Shuoling Chen, Chang Gao, Tianyang Yu, Yueyang Qu, Gary Guishan Xiao, Zunnan Huang · 2021 · Frontiers in Oncology
6. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma
   Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean‐Luc Van Laethem, Tatjana Arsenijevic · 2023 · Cells
7. Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
   Johannes Byrling, Theresa Kristl, Dingyuan Hu, Indira Plá, Aniel Sánchez, Agata Sasor, Roland E. Andersson, György Marko‐Varga, Bodil Andersson · 2020 · Journal of Translational Medicine
8. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
   Meili Zhang, J. Jeya Vandana, Lauretta A. Lacko, Shuibing Chen · 2020 · Stem Cell Research
9. Overexpression of pyruvate dehydrogenase phosphatase 1 promotes the progression of pancreatic adenocarcinoma by regulating energy-related AMPK/mTOR signaling
   Ye Li, Jia Shen, Chien‐shan Cheng, Huifeng Gao, Jiangang Zhao, Lianyu Chen · 2020 · Cell & Bioscience
10. Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus
    Phil A. Hart, Dana K. Andersen, Maxim S. Petrov, Mark O. Goodarzi · 2021 · Current Opinion in Gastroenterology
11. Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer
    Wenna Jiang, Lu Qiao, Yawei Han, Aimin Zhang, Haohua An, Jiawei Xiao, Li Ren · 2021 · Annals of Translational Medicine
12. Stable and sensitive SERS-based immunoassay enabled by core-shell immunoprobe and paper-based immunosubstrate
    Ziluo Su, Hongmei Liu, Ying Chen, Chenjie Gu, Guodong Wei, Tao Jiang · 2021 · Sensors and Actuators B Chemical
13. Biomarkers for the early detection of PDAC
    Katrina Ray · 2017 · Nature Reviews Gastroenterology & Hepatology
14. Risk factors of pancreatic cancer and their possible uses in diagnostics
    Jitka Lang, Lumír Kunovský, Zdeněk Kala, Jan Trna · 2020 · Neoplasma
15. THBS2 promotes gastric cancer progression and stemness via the Notch signaling pathway
    Zhengyao Chang · 2024 · American Journal of Cancer Research
16. The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection
    Yuanwei Xu, Yuefan Wang, Naseruddin Höti, David J. Clark, Shao‐Yung Chen, Hui Zhang · 2021 · Mass Spectrometry Reviews
17. The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
    Le Ren, Yue Yu · 2018 · Therapeutics and Clinical Risk Management
18. Osteonectin as a screening marker for pancreatic cancer: A prospective study
    Angeliki Papapanagiotou, George G. Sgourakis, Kyriakos Karkoulias, Dimitris Raptis, Edward T. Parkin, Pantelis Brotzakis, Sanjay Panchal, Athanasios G. Papavassiliou · 2018 · Journal of International Medical Research
19. Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
    Monika Kapszewicz, Ewa Małecka-Wojciesko · 2021 · Journal of Clinical Medicine
20. Recent advances in understanding pancreatic cancer
    Martyn Charles Stott, Lucy S. Oldfield, Jessica J. Hale, Eithne Costello, Christopher Michael Halloran · 2022 · Faculty Reviews
21. Establishment and validation of a plasma oncofetal chondroitin sulfated proteoglycan for pan-cancer detection
    Pei‐Fen Zhang, Ziyi Wu, Wen-Bin Zhang, Yong‐Qiao He, Kexin Chen, Tong‐Min Wang, Haixin Li, Hong Zheng, Dan‐Hua Li, Da-Wei Yang et al. · 2023 · Nature Communications
22. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN
    Liu, Ying, Kaur, Sukhwinder, Huang, Ying, Fahrmann, Johannes F., Rinaudo, Jo Ann, Hanash, Samir M., Batra, Surinder K., Singhi, Aatur D., Brand, Randall E., Maitra, Anirban et al. · 2020 · Cancer Epidemiology, Biomarkers & Prevention
23. N6 ‐methyladenosine RNA demethylase FTO regulates extracellular matrix‐related genes and promotes pancreatic cancer cell migration and invasion
    Wei Wang, Ying He, Lun Wu, Lulu Zhai, Long‐Jiang Chen, Lichao Yao, Kaihuan Yu, Zhi‐Gang Tang · 2022 · Cancer Medicine
24. Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma
    Chang Xu, Liang-Hua Yan, Xiao-Ya Guan, Zhen Wang, Jian-Hui Wu, Ang Lv, Dao-Ning Liu, Fa-Qiang Liu, B. Dong, Min Zhao et al. · 2022 · International Journal on Biological Sciences
25. Omics Approaches in Pancreatic Adenocarcinoma
    Iranzu González‐Borja, Antonio Viúdez, Saioa Goñi, Enrique Santamaría, Estefanía Carrasco‐García, Jairo Pérez‐Sanz, Irene Hernández-García, Pablo Sala Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte et al. · 2019 · Cancers
26. Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm
    Rachel E. Simpson, Michele Yip-Schneider, Huangbing Wu, Hao Fan, Ziyue Liu, Murray Korc, Jianjun Zhang, Christian Max Schmidt · 2018 · The American Journal of Surgery
27. Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer
    Haruyoshi Tanaka, Koji Tamura, Toshiya Abe, Takeichi Yoshida, Anne M. Macgregor-Das, Mohamad H. Dbouk, Amanda L. Blackford, Michael W. Borges, Anne Marie Lennon, Jin Peng He et al. · 2021 · Clinical Gastroenterology and Hepatology
28. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics
    Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos‐Delgado, Céline Basset, Benoît Thibault, Julie Guillermet‐Guibert · 2018 · Cancers
29. Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
    Fei Xiong, Guanhua Wu, Bing Wang, Yongjun Chen · 2021 · Cancer Cell International
30. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)
    Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel Ángel Álvarez-Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‐Honduvilla, Agustı́n Albillos, Julia Buján, Melchor Álvarez‐Mon et al. · 2021 · Oncology Letters
31. Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer
    Shu-Heng Jiang, Dejun Liu, Li-Peng Hu, Shan Zhang, Yanqiu Yu, Yongwei Sun, Jianguang Ji, Zhigang Zhang · 2022 · EBioMedicine
32. Gold Nanoparticle Probe-Assisted Antigen-Counting Chip Using SEM
    Xin Zhou, Chih‐Tsung Yang, Qiaoshu Xu, Zhichao Lou, Zhengfeng Xu, Benjamin Thierry, Ning Gu · 2019 · ACS Applied Materials & Interfaces
33. Development of PDAC diagnosis and prognosis evaluation models based on machine learning
    Yingqi Xiao, Shixin Sun, Naxin Zheng, Jing Zhao, Xiaohan Li, Jianmin Xu, Han Li, Chenran Du, Lijun Zeng, Juling Zhang et al. · 2025 · BMC Cancer
34. Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
    Kenneth H. Yu, Mark Ricigliano, Brian McCarthy, Joanne F. Chou, Marinela Capanu, Brandon Cooper, Andrew Bartlett, Christina M. Covington, Maeve Aine Lowery, Eileen Mary O'Reilly · 2018 · Cancers
35. Sweet Predictions Speak Volumes for Early Detection of Pancreatic Cancer
    Kjetil Søreide · 2018 · Gastroenterology
36. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review
    Natália Calanzani, Paige Druce, Claudia M. Snudden, Kristi M. Milley, Rachel A. Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martínez-Gutiérrez, Jasmeen Oberoi, Garth Funston et al. · 2020 · Advances in Therapy
37. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
    Matthew A. Firpo, Kenneth M. Boucher, Josh M. Bleicher, Gayatri Deepti Khanderao, Alessandra Rosati, Katherine E. Poruk, Sama Kamal, Liberato Marzullo, Margot De Marco, Antonia Falco et al. · 2023 · JCO Clinical Cancer Informatics
38. An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum
    Rex Devasahayam Arokia Balaya, Partho Sen, Caroline W. Grant, Roman M. Zenka, Marimuthu Sappani, Lakshmanan Jeyaseelan, Arjun P. Athreya, Richard K. Kandasamy, Akhilesh Pandey, Seul Kee Byeon · 2024 · Journal of Gastroenterology
39. Research advances of secretory proteins in malignant tumors
    Na Zhang, Jia‐Jie Hao, Yan Cai, Ming‐Rong Wang · 2021 · Chinese Journal of Cancer Research
40. Model-based screening for pancreatic cancer in Sweden
    Tomasz Draus, Daniel Ansari, Roland E. Andersson · 2022 · Scandinavian Journal of Gastroenterology
41. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma
    Hai‐Jie Hu, Yayun Zhu, Ning Pu, Richard A. Burkhart, William R. Burns, Daniel A. Laheru, Lei Zheng, Jin Peng He, Michael Goggins, Jun Yu · 2020 · Journal of the American College of Surgeons
42. Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
    Johannes Byrling, Katarzyna Said Hilmersson, Daniel Ansari, Roland E. Andersson, Bodil Andersson · 2021 · Clinical & Translational Oncology
43. Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC
    Philip Dujardin, Anna K. Baginska, Sebastian Urban, Barbara M. Grüner · 2021 · Cancers
44. Pluripotency Stemness and Cancer: More Questions than Answers
    Jiřı́ Hatina, Michaela Kripnerová, Zbyněk Houdek, Martin Pešta, Filip Tichánek · 2021 · Advances in experimental medicine and biology
45. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma
    Yong Dong Jiang, Xiaohu Zheng, Defeng Jiao, Peng Chen, Yechuan Xu, Haiming Wei, Yeben Qian · 2019 · EBioMedicine
46. Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Zilin Yang, Jia Huang, Xuejiao Wu, Yufen Zhou, Yuming Tang, Ying Zhu, Baiwen Li, Xi Chen, Weiyan Yao · 2024 · Journal of Cancer
47. Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men
    Luana Greco, Federica Rubbino, Luigi Laghi · 2022 · Cancers
48. Single nanoparticle analysis for homogeneous immunoassay of CA19-9 for serological evaluation
    Min Jiang, Zili Huang, Xin Sheng Zhao, Rui Liu, Yi Lv · 2021 · Journal of Analytical Atomic Spectrometry
49. Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures
    Jungsun Kim, Taelor J. Ekstrom, Wenli Yang, Greg Donahue, Dmytro Grygoryev, Thuy T. M. Ngo, John L. Muschler, Terry K. Morgan, Kenneth S. Zaret · 2021 · Molecular Cancer Research
50. The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer
    Federica Vitale, Lorenzo Zileri Dal Verme, Mattia Paratore, Marcantonio Negri, Enrico Celestino Nista, Maria Elena Ainora, Giorgio Esposto, Irene Mignini, Raffaele Borriello, Linda Galasso et al. · 2024 · Biomedicines
51. Organoid models of gastrointestinal Neoplasms: Origin, current status and future applications in personalized medicine
    Yi Pan, Shuliang Zhao, Zhijun Cao · 2018 · Genes & Diseases
52. The “K-Sign”—A Novel CT Finding Suggestive before the Appearance of Pancreatic Cancer
    Yuko Kobashi, Masateru Uchiyama, Junichi Matsui · 2021 · Cancers
53. Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics
    Sitong Zhang, Danyang Li, Yingjia Liu, Chunlian Qin, Lingjun Tong, Lizhou Xu · 2023 · Extracellular Vesicle
54. Morphology and optical properties of Au–Ag hybrid nanoparticles regulation and its ultra-sensitive SERS immunoassay detection in carbohydrate antigen 19-9
    Gaofeng Wu, Jian Zhu, Guojun Weng, Hao-yu Cai, Jian-Jun Li, Jun‐Wu Zhao · 2024 · Talanta
55. Pancreatic Cancer Surveillance and Novel Strategies for Screening
    Beth Dudley, Randall E. Brand · 2021 · Gastrointestinal Endoscopy Clinics of North America
56. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9
    Masato Ono, Yusuke Ono, Toru Nakamura, Takahiro Tsuchikawa, Tomotaka Kuraya, Shota Kuwabara, Yoshitsugu Nakanishi, Toshimichi Asano, Aya Matsui, Kimitaka Tanaka et al. · 2022 · Annals of Surgical Oncology
57. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival
    Julie Earl, Emma Barreto, María Castillo, Raquel Fuentes, Mercedes Rodríguez-Garrote, Reyes Ferreiro, Pablo Reguera, Gloria Muñoz, David García‐Seisdedos, Jorge López et al. · 2021 · Cancers
58. Cellular reprogramming to model and study epigenetic alterations in cancer
    Jungsun Kim · 2020 · Stem Cell Research
59. CancerEMC: frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA
    Saifur Rahaman, Xiangtao Li, Jun Qing Yu, Ka‐Chun Wong · 2021 · Bioinformatics
60. Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer
    Lanzhi Li, Jie Dong, Lei Fu, Xinhua Xia, Feng Pan, Ning Yuan · 2021 · Journal of Oncology
61. Proteome-Wide Investigation of Proline Hydroxylation in Pancreatic Ductal Adenocarcinoma Using DiLeu Isobaric Labeling Strategy
    Feixuan Wu, Dylan Nicholas Tabang, Danqing Wang, Jon S. Odorico, Lingjun Li · 2025 · Molecular & Cellular Proteomics
62. Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
    Yuxiang Lin, E. Lin, Yan Li, Xiaobin Chen, Minyan Chen, Jun Huang, Wenhui Guo, Lili Chen, Long Wu, Xiang Zhang et al. · 2022 · Pathology & Oncology Research
63. Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma
    Jungsun Kim, Kenneth S. Zaret · 2018 · Methods in molecular biology
64. Mathematical Modeling of The Challenge to Detect Pancreatic Adenocarcinoma Early with Biomarkers
    Alex Root · 2019 · Challenges
65. Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma
    Federica Di Marco, Maria Concetta Cufaro, Verena Damiani, Beatrice Dufrusine, Erika Pizzinato, Fabio Di Ferdinando, Gianluca Sala, Rossano Lattanzio, Enrico Dainese, Luca Federici et al. · 2025 · Oncogenesis
66. Distribution of serum Thrombospondin-2, a novel tumor marker, in general population and cancer patients in China
    Seyin Zou, Jie Li, Junping Yan, Jinhong Xu, Maorui Lin, Donglin Cao · 2021 · Clinica Chimica Acta
67. THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
    Phyllis A. Gimotty, Jacob Edward Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael Joseph Lariviere, Mark H. O’Hara, Kim A. Reiss, Peter James O'Dwyer, Bryson W. Katona et al. · 2021 · Oncotarget
68. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation
    Hamid Taghvaei Javanshir, Mohammad Amin Malekraeisi, Seyedeh Sanaz Seyed Ebrahimi, Ahmad Bereimipour, Sara Fakharian Kashani, Amir Abbas Bostaki, Habibollah Mahmoodzadeh, Karim Nayernia · 2022 · Journal of Medicine and Life
69. The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer
    Dong Luo, Yunfei Liu, Shuai Yuan, Xianyun Bi, Yongchao Yang, Hongwei Zhu, Zhiqiang Li, Liandong Ji, Xiao Yu · 2022 · Pathology - Research and Practice
70. Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia
    Yuqiu Ge, Bin Xu, Hongzhou Cai, Wentao Jing, Qiong Ouyang, Qinbo Yuan, Xu Li, Yuanming Fan, Yang Shen, Qianqian Shi et al. · 2022 · Journal of Cancer Research and Clinical Oncology
71. Cell-Surface Glycan Labeling and Sensing
    Yiran Li, Lele Wang, Lin Ding, Huangxian Ju · 2023 · Targets
72. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead
    Hyunsoo Kim, Joonho Park, Joseph I. Wang, Youngsoo Kim · 2017 · Expert Review of Proteomics
73. Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma
    Alison Farley, David R. Braxton, Jonathan Li, Karl M. Trounson, Subhanwita Sakar-Dey, Bhavana Nayer, Tatsuhiko Ikeda, Kevin X. Lau, Winita Hardikar, Kouichi Hasegawa et al. · 2019 · Scientific Reports
74. Multi-histidine functionalized material for the specific enrichment of sialylated glycopeptides
    Shuyue Wang, Hongqiang Qin, Jing Dong, Lianghai Hu, Mingliang Ye · 2020 · Journal of Chromatography A
75. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
    Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon‐Koon Yoong, Azlina Abdul Aziz, Sarni Mat Junit, P. Subramanian · 2022 · International Journal of Molecular Sciences
76. N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer
    Yan-Rong Wen, Xia-Wen Lin, Yuwen Zhou, Lei Xu, Junli Zhang, Cuiying Chen, Jian He · 2024 · World Journal of Gastrointestinal Oncology
77. Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5th edition)
    Maoquan Li · 2021 · Journal of interventional medicine
78. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up
    C. Sok, Karunesh Polireddy, David A. Kooby · 2024 · HepatoBiliary Surgery and Nutrition
79. Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
    Shelize Sadrudin Khakoo, Angelica Petrillo, Massimiliano Salati, Abdul Muhith, Jessica Evangelista, Silvia Seghezzi, Fausto Petrelli, Gianluca Tomasello, Michele Ghidini · 2021 · Cancers
80. Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer
    Lang Xiong, Cheng Zhu, Yuhai Lu, Mao Chen, Mingwei Li · 2023 · Journal of Cancer Research and Clinical Oncology
81. Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review
    Yukun Liu, Changlei Li, Xiaotong Cui, Miaomiao Li, Shiguo Liu, Zusen Wang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
82. DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis
    Xiaowen Gong, Yuerong Xuan, Chengshuai Pang, Chenyang Dong, Rui Cao, Zhigang Wei, Chaojie Liang · 2024 · Clinica Chimica Acta
83. Electrochemical immunosensor for point-of-care quantitative detection of tumor markers based on personal glucometer
    Yang J. Xu, Huiqiang Wang · 2022 · Journal of Electroanalytical Chemistry
84. Ultra rapid biosensors for detecting carcinoma biomarkers
    Sweeti Ahlawat, Krishna Pal Singh, Anuj Nehra, Mohommad Arif, Veena Pandey · 2022 · Materials Express
85. Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine
    He Zhang, Pengpeng Wu, Chenbo Guo, Caiqin Zhang, Yong Zhao, Dengxu Tan, Jiaze An, Changhong Shi · 2022 · Biochemistry and Biophysics Reports
86. Blood-Based Biomarkers in the Diagnosis and Risk Stratification of Pancreatic Cysts
    Matthew T. Peller, Koushik K. Das · 2023 · Gastrointestinal Endoscopy Clinics of North America
87. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol
    Hugh Claridge, Claire A. Price, Rofique Ali, Elizabeth A. Cooke, Simon de Lusignan, Adam Harvey-Sullivan, Catherine Hodges, Natalia I. Khalaf, Dean O’Callaghan, Ali Stunt et al. · 2024 · BMJ Open
88. Development of a serum protein biomarker panel for the diagnosis of pancreatic ductal adenocarcinoma using a machine learning approach
    Dong Woo Shin, Je‐Yoel Cho, Sukki Cho, Yuna Youn, Jin‐Hyeok Hwang · 2025 · Scientific Reports
89. Extracellular vesicle biomarkers in pancreatic ductal adenocarcinoma: from bulk detection to single-extracellular vesicle profiling and endoscopic liquid biopsy
    Nana Shimamoto, Kazuki Sumiyama, Yu Fujita · 2026 · Journal of Gastroenterology
90. Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma
    Kuntal Halder, Erkut Hasan Borazanci, Gayle Jameson, Lin Wei, Amber Vrana, Derek Cridebring, Susan Tsai, Mohammed Aldakkak, Douglas B. Evans, Masamichi Hayashi et al. · 2025 · British Journal of Cancer
91. Biomarkers for the Early Detection of Pancreatic Ductal Adenocarcinoma
    Carl A.K. Borrebaeck, Linda Dexlin Mellby, Thomas Charles King · 2022 · Exon Publications eBooks
92. Diagnostic and Prognostic Roles of Thrombospondin‐2 in Digestive System Cancers
    Feiqiong Gao, Wenyi Chen, Tingxiao Zhao, Jiong Yu, Xudong Feng, Lan Wang, Tianan Jiang, Hongcui Cao · 2022 · BioMed Research International
93. Multiplexed Quantitation of Plasma Proteins by Targeted Mass Spectrometry for Early Diagnosis of Pancreatic Ductal Adenocarcinoma
    D. Korobkov, Ivan A. Molodtsov, Alexey S. Kononikhin, Anna E. Bugrova, Maria I. Indeykina, Alexander G. Brzhozovskiy, Dmitry Yu. Kanner, Е. Н. Николаев, Elena Vasilieva, Alexey A. Komissarov · 2025 · International Journal of Molecular Sciences
94. Study on the Detection of Pancreatic Cancer Tumor Markers Based on Planar DNA Nanostructure Biosensors
    Xiuyan Jin, Hao Zhang, Chunyang Zhou, Xin Wang · 2024 · IEEE International Conference on Manipulation, Manufacturing and Measurement on the Nanoscale (3M-NANO)
95. Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening
    Yue Huang, Chengzhi Sun, Xiangyuan Gao, Siqi Zhai, Guosheng Wang, Fan Zhang · 2025 · Discover Oncology
96. Mass spectrometry–based proteomics technology in pancreatic cancer research
    Xue Jun Sun, Siyuan Wang, Catherine C. L. Wong · 2023 · Journal of Pancreatology
97. Pancreatic Cancer Screening among High-risk Individuals
    Kevin M. Turner, Sameer H. Patel · 2024 · Surgical Clinics of North America
98. Rapid and Sensitive Detection of Thrombospondin-2 Using Nanoparticle Sensors for Cancer Screening and Prognosis
    Maziyar Kalateh Mohammadi, Seyedsina Mirjalili, Md Ashif Ikbal, Hao Xie, Chao Wang · 2025 · Micromachines
99. [Detection of chitinase 3-like 1 combined with other biomarkers for diagnosis of pancreatic cancer].
    Yan-Fen Ma, He Lm, Qing Wu, Yun-Feng Ma, Xiao-Qin Wang · 2018 · Europe PMC (PubMed Central)
100. Comprehensive Analysis of the Expression and Prognostic Significance of THBSs in Breast Cancer
     Jun Wang, Xuebing Zhan, Qian Luo, Y. Kuang, Xiao Mei Liang, Junjie Wang, Xiangxiang Tao, Entao Sun, Bing Chen · 2021 · Research Square